Extensive innate immune gene activation accompanies brain aging, increasing vulnerability to cognitive decline and neurodegeneration: a microarray study
Year: 2012
Type: article
Study design: Observational Study
Abstract: BACKGROUND: This study undertakes a systematic and comprehensive analysis of brain gene expression profiles of immune/inflammation-related genes in aging and Alzheimer's disease (AD). METHODS: In a well-powered microarray study of young (20 to 59 years), aged (60 to 99 years), and AD (74 to 95 years) cases, gene responses were assessed in the hippocampus, entorhinal cortex, superior frontal gyrus, and post-central gyrus. RESULTS: Several novel concepts emerge. First, immune/inflammation-related genes showed major changes in gene expression over the course of cognitively normal aging, with the extent of gene response far greater in aging than in AD. Of the 759 immune-related probesets interrogated on the microarray, approximately 40% were significantly altered in the SFG, PCG and HC with increasing age, with the majority upregulated (64 to 86%). In contrast, far fewer immune/inflammation genes were significantly changed in the transition to AD (approximately 6% of immune-related probesets), with gene responses primarily restricted to the SFG and HC. Second, relatively few significant changes in immune/inflammation genes were detected in the EC either in aging or AD, although many genes in the EC showed similar trends in responses as in the other brain regions. Third, immune/inflammation genes undergo gender-specific patterns of response in aging and AD, with the most pronounced differences emerging in aging. Finally, there was widespread upregulation of genes reflecting activation of microglia and perivascular macrophages in the aging brain, coupled with a downregulation of select factors (TOLLIP, fractalkine) that when present curtail microglial/macrophage activation. Notably, essentially all pathways of the innate immune system were upregulated in aging, including numerous complement components, genes involved in toll-like receptor signaling and inflammasome signaling, as well as genes coding for immunoglobulin (Fc) receptors and human leukocyte antigens I and II. CONCLUSIONS: Unexpectedly, the extent of innate immune gene upregulation in AD was modest relative to the robust response apparent in the aged brain, consistent with the emerging idea of a critical involvement of inflammation in the earliest stages, perhaps even in the preclinical stage, of AD. Ultimately, our data suggest that an important strategy to maintain cognitive health and resilience involves reducing chronic innate immune activation that should be initiated in late midlife.
Source: Journal of Neuroinflammation
Language: English
Subfield: Neurology
Field: Neuroscience
Domain: Life Sciences
Keywords: brain aging, Alzheimer's disease, innate immunity, neuroinflammation, immune gene expression, microglial activation, perivascular macrophages, cognitive decline, neurodegeneration, hippocampus, entorhinal cortex, superior frontal gyrus, postcentral gyrus, sex differences, Toll-like receptor signaling, inflammasome, complement system, Tollip, fractalkine, preclinical Alzheimer's disease
Open Access status: gold
Estimated APC paid: $4,090
Awards: Behavioral and Neural Plasticity in the Aged, Gene Expression, Compensation Mechanisms, and Successful Cognitive Aging, G2161113364, G3250808129, The Alzheimer's Disease Research Center at the University of California, Irvine, Hypertension, Cerebral Amyloid Angiopathy and Neuroinflammation, Brain Aging & Gene Expression Patterns Using Microarrays, Arizona Alzheimer's Disease Core Center, G7924111682, G9000294252, G961669115
OpenAlex ID: W2117266418
